SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Aug-24 5:09 PM View: | Lumos Pharma, Inc. (LUMO) | 06-Aug-24 | Sale (Planned) | 3,407 | $1.89 | $6,425.60 | (21%) 16.06K to 12.65K | |
05-Aug-24 5:18 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Aug-24 | Payment of Exercise | 1,593 | $1.79 | $2,851.47 | (9%) 17.65K to 16.06K | |
03-Apr-24 5:10 PM View: | Lumos Pharma, Inc. (LUMO) | 03-Apr-24 | Sale (Planned) | 2,214 | $2.78 | $6,143.85 | (11%) 19.37K to 17.15K | |
03-Apr-24 5:10 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Grant | 2,000 | $2.84 | $5,680.00 | 11% 18.4K to 20.4K | |
03-Apr-24 5:10 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Apr-24 | Payment of Exercise | 1,036 | $2.84 | $2,942.24 | (5%) 20.4K to 19.37K | |
07-Feb-24 5:22 PM View: | Lumos Pharma, Inc. (LUMO) | 06-Feb-24 | Sale (Planned) | 438 | $3.03 | $1,328.02 | (2%) 18.84K to 18.4K | |
05-Feb-24 5:55 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-24 | Payment of Exercise | 366 | $3.01 | $1,101.66 | (2%) 19.21K to 18.84K | |
03-Aug-23 4:58 PM View: | Lumos Pharma, Inc. (LUMO) | 02-Aug-23 | Sale (Planned) | 3,407 | $3.20 | $10,919.40 | (15%) 22.11K to 18.71K | |
03-Aug-23 4:58 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Aug-23 | Payment of Exercise | 1,593 | $3.28 | $5,225.04 | (7%) 23.71K to 22.11K | |
04-Apr-23 5:22 PM View: | Lumos Pharma, Inc. (LUMO) | 04-Apr-23 | Sale (Planned) | 2,214 | $3.27 | $7,239.78 | (9%) 25.42K to 23.21K | |
04-Apr-23 5:22 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Apr-23 | Payment of Exercise | 1,036 | $3.31 | $3,429.16 | (4%) 26.46K to 25.42K | |
03-Feb-23 5:03 PM View: | Lumos Pharma, Inc. (LUMO) | 02-Feb-23 | Sale (Planned) | 439 | $3.53 | $1,549.67 | (2%) 26.9K to 26.46K | |
03-Feb-23 5:03 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Grant | 2,000 | $3.52 | $7,040.00 | 8% 25.1K to 27.1K | |
03-Feb-23 5:03 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-23 | Payment of Exercise | 206 | $3.52 | $725.12 | (< 1%) 27.1K to 26.9K | |
03-Aug-22 11:25 AM View: | Lumos Pharma, Inc. (LUMO) | 02-Aug-22 | Sale (Planned) | 3,407 | $8.11 | $27,630.80 | (12%) 28.01K to 24.6K | |
03-Aug-22 11:25 AM View: | Lumos Pharma, Inc. (LUMO) | 01-Aug-22 | Payment of Exercise | 1,593 | $8.17 | $13,014.80 | (5%) 29.6K to 28.01K | |
07-Jun-22 4:23 PM View: | Lumos Pharma, Inc. (LUMO) | 06-Jun-22 | Private Sale (Planned) | 169 | $7.62 | $1,287.78 | (< 1%) 29.27K to 29.1K | |
05-Apr-22 5:29 PM View: | Lumos Pharma, Inc. (LUMO) | 05-Apr-22 | Sale (Planned) | 2,214 | $8.32 | $18,420.50 | (7%) 31.48K to 29.27K | |
05-Apr-22 5:29 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Apr-22 | Payment of Exercise | 1,036 | $9.23 | $9,562.28 | (3%) 32.52K to 31.48K | |
03-Feb-22 4:36 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-22 | Grant | 1,500 | $10.02 | $15,030.00 | 5% 31.12K to 32.62K | |
03-Feb-22 4:36 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-22 | Payment of Exercise | 100 | $10.02 | $1,002.00 | (< 1%) 32.62K to 32.52K | |
10-Sep-21 4:58 PM View: | Lumos Pharma, Inc. (LUMO) | 08-Sep-21 | Market Sale (Planned) | 2,214 | $11.30 | $25,018.20 | (7%) 33.23K to 31.01K | 2% |
03-Aug-21 6:09 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Aug-21 | Grant | 20,000 | -- | -- | 151% 13.23K to 33.23K | |
05-Apr-21 5:50 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Apr-21 | Payment of Exercise | 1,036 | $12.25 | $12,691.00 | (7%) 14.26K to 13.23K | 0% |
03-Feb-21 6:52 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Feb-21 | Grant | 1,078 | -- | -- | 8% 13.18K to 14.26K | |
03-Apr-20 6:22 PM View: | Lumos Pharma, Inc. (LUMO) | 01-Apr-20 | Grant | 13,000 | -- | -- | 100% 0 to 13.0K |